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Alzheimer’s disease is characterized by progressive cognitive decline and neuronal 
loss. The changes associated with this neurodegenerative disease start years 
before the clinical diagnosis can be made. So far no single diagnostic modality 
or biomarker is available with high enough sensitivity and specificity to establish 
an accurate diagnosis in the individual patient. Furthermore, there is need for 
prognostic factors that can accurately track disease progression.
Magnetic Resonance Imaging offers the possibility to visualize structural changes 
associated with neurodegenerative disease in vivo. Nevertheless, the diagnostic 
accuracy leaves room for improvement, partly because cross-sectional analysis 
has the disadvantage of confounding influence of inter-individual variability in 
brain structure and ageing. 
This thesis aspires to expand insights in the use of longitudinal whole-brain 
and regional MR imaging in the early detection, diagnosis and prognosis of AD. 
Moreover, it explores the association of these atrophy markers with clinical, genetic 
and cerebrospinal fluid biomarkers, aiming to develop a better understanding 
of the course of the disease, eventually improving the effectiveness of patient 
management.
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